New 52 Week Low Today

My Portfolio
+
LINK YOUR PORTFOLIO

AnGes Inc 4563.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 3:30 PM JST
47.00quote price arrow down-1.00 (-2.08%)
Volume
547,800
52 week range
47.00 - 120.00
Loading...
  • Open48.00
  • Day High48.00
  • Day Low47.00
  • Prev Close48.00
  • 52 Week High120.00
  • 52 Week High Date09/01/25
  • 52 Week Low47.00
  • 52 Week Low Date06/03/26

Latest On AnGes Inc

 

Key Stats

  • Market Cap18.665B
  • Shares Out397.13M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.71

Latest On AnGes Inc

 

KEY STATS

  • Open48.00
  • Day High48.00
  • Day Low47.00
  • Prev Close48.00
  • 52 Week High120.00
  • 52 Week High Date09/01/25
  • 52 Week Low47.00
  • 52 Week Low Date06/03/26
  • Market Cap18.665B
  • Shares Out397.13M
  • 10 Day Average Volume1.33M
  • Dividend-
  • Dividend Yield-
  • Beta0.71

RATIOS/PROFITABILITY

  • EPS (TTM)-25.70
  • P/E (TTM)-1.83
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-5.326B
  • ROE (TTM)-193.09%
  • Revenue (TTM)908.654M
  • Gross Margin (TTM)38.14%
  • Net Margin (TTM)-556.94%
  • Debt To Equity (MRQ)34.01%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to...
Ei Yamada
President, Executive President, Chief Executive Officer, President of Subsidiary, Representative Director
Address
Saito Bio-Incubator, 7-7-15, Saito-Asagi
Ibaraki-shi, OSK
567-0085
Japan